These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8363649)

  • 1. Excretion balance and urinary metabolism of indobufen in rats and mice.
    Grubb N; Caldwell J; Strolin-Benedetti M
    Biochem Pharmacol; 1993 Aug; 46(4):759-61. PubMed ID: 8363649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion balance and urinary metabolites of the S-enantiomer of indobufen in rats and mice.
    Grubb N; Caldwell J; Strolin-Benedetti M
    Biochem Pharmacol; 1993 Oct; 46(8):1507-10. PubMed ID: 8240403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dispositional enantioselectivity of indobufen in man.
    Strolm Benedetti M; Frigerio E; Tamassia V; Noseda G; Caldwell J
    Biochem Pharmacol; 1992 May; 43(9):2032-4. PubMed ID: 1596290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dispositional enantioselectivity of indobufen in rat and mouse.
    Strolin Benedetti M; Moro E; Frigerio E; Jannuzzo MG; Roncucci R; Caldwell J
    Biochem Pharmacol; 1990 Oct; 40(8):1719-23. PubMed ID: 2242009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man.
    Fuccella LM; Corvi G; Moro E; Pogliani E; Tamassia V; Tosolini G
    Eur J Clin Pharmacol; 1979 Jun; 15(5):323-7. PubMed ID: 456403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of 14C-labelled 2-[p-(1-oxo-2-isoindolinyl)phenyl]butyric acid, (indobufen or K 3920) in blood, platelets and platelet components.
    Vinazzer H; Zolle I; Fuccella LM; Valzelli G
    Thromb Res; 1980 Feb 1-15; 17(3-4):303-16. PubMed ID: 7368166
    [No Abstract]   [Full Text] [Related]  

  • 9. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
    Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on the pharmacokinetics of indobufen.
    Savazzi GM; Castiglioni A; Cavatorta A; Garini G; Montanari M; Borghetti A
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):265-9. PubMed ID: 3733275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK; Caldwell J
    Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis.
    Glówka FK; Strzelecka D; Zapalski S
    Chirality; 2001 Jun; 13(6):308-12. PubMed ID: 11370020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant Activities of Indobufen, an Antiplatelet Drug.
    Liu J; Xu D; Xia N; Hou K; Chen S; Wang Y; Li Y
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Effects of Indobufen and Warfarin in a Rat Model of Adenine-Induced Chronic Kidney Disease.
    Lou X; Jin J; Gong J; Zhao L; Li Y; He Q
    Med Sci Monit; 2019 May; 25():3566-3572. PubMed ID: 31086128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets.
    Dmoszyńska A; Walter-Croneck A; Ledwozyw A
    Thromb Res; 1995 Sep; 79(5-6):483-90. PubMed ID: 7502274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
    Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
    Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.